MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Black Diamond Therapeutics, Inc.(NASDAQ: BDTX)*
Organization & Developments: Black Diamond Therapeutics
Parents
Black Diamond Therapeutics, Inc.(NASDAQ: BDTX)*
Children
*Black Diamond Therapeutics, Inc., a precision oncology medicine company, discovers and develops small molecule, tumor-agnostic therapies.
2022: Black Diamond runs into rocky terrain, trims 30% of workforce and cuts precision oncology program
2024: Black Diamond Therapeutics: Emerging Data In EGFR-Mutant NSCLC And GBM_seekingalpha.com
2024: Black Diamond Therapeutics: Speculative Buy With Precision Oncology Catalysts
2024: Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type Of Lung Cancer Resistant To AstraZeneca's Drug
2024: Black Diamond: EGFRm NSCLC Targeting Continues With Q1 Of 2025 Data
2025: Black Diamond Therapeutics surges on licensing deal
2025: Black Diamond Therapeutics: In Decline, But Why?seekingalpha.com
2025: Black Diamond Therapeutics: Targeted Approach And Early Efficacy Signals Create Potential For Significant Upside
Jumps
Finance & Acquisitions: Black Diamond Therapeutics
Key People: Black Diamond Therapeutics